🧪 Tirzepatide – 5mg (Research Peptide)
Tirzepatide is a synthetic peptide classified as a dual agonist, targeting both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors. It has been studied in clinical and laboratory research for its potential role in glucose metabolism, insulin regulation, and appetite pathways.
Key Research Notes:
🔬 Mechanism of Action – Simultaneously activates GLP-1 and GIP receptors, engaging two key incretin pathways.
🧬 Metabolic Research – Investigated for its effects on insulin secretion, glucose balance, and energy regulation.
⚡ Dual Agonist Profile – Distinguishes it from single-pathway analogs like GLP-1–only agonists.
📚 Research Applications – Used in experimental settings studying metabolic disorders, endocrine function, and incretin-based mechanisms.
Form: 5mg lyophilized peptide powder per vial – supplied for laboratory research.
Disclaimer:Tirzepatide is intended strictly for laboratory and research purposes only. It is not approved for human consumption, medical use, or dietary supplementation. No therapeutic or performance claims are made.
